Author: admin
The tiny, fragrant dried flower buds known as cloves are far more than just a common kitchen spice. For thousands of years, this potent botanical has been revered across the globe—from the kitchens of Asia to the ancient medical traditions of Ayurveda and Chinese medicine. If you’ve ever asked, what are the benefits of cloves or pondered their true potential, you’re about to discover why these little spice buds are a powerhouse of wellness. This complete guide dives deep into the profound health benefits of cloves, exploring how they can support everything from digestion and immunity to sexual wellness, hair…
As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, a much smaller potential rival spotlighted positive mid-stage clinical data that captivated investors enough to send its share price more than doubling this past week. Structure Therapeutics (NASDAQ: GPCR) shares soared 102% after it reported positive data from its Phase II ACCESS clinical program assessing its oral GLP-1 candidate aleniglipron in people with obesity and/or overweight with at least one weight-related co-morbidity. Aleniglipron (formerly GSBR-1290) is designed to be a biased G protein-coupled receptor…
Gluten-free cereal options are breakfast cereals that are made without gluten-containing ingredients and, crucially, are processed to minimize or eliminate the risk of cross-contamination from wheat, barley, or rye. Gluten, derived from the Latin word for “glue,” is a general term for the proteins found in these grains. It is responsible for the elastic texture of dough, but for those with Celiac Disease, consuming even trace amounts can trigger a severe autoimmune response that damages the small intestine. For individuals with NCGS, it can cause digestive and systemic symptoms. So, what cereal does not have gluten? The modern market offers…
Rather than rely on conventional immunotherapies, Laguna Bio is betting on engineered microbes to enhance the immune response against cancer. Founders Jonathan Kotula, Dan Portnoy, and Russell Carrington bring together decades of expertise in microbiology, immunology, and biotechnology. At the heart of their work is a highly attenuated strain of Listeria monocytogenes, capable of safely eliciting a strong, multifactorial reaction that activates rare gamma delta T cells, which proliferate and activate in response to cells that phagocytose Listeria. The Laguna Bio team will soon test their lead Listeria strain in patients with pediatric leukemia, with the goal of long-term cancer…
Imagine this scenario: A researcher prepares for a day in the field. They start their day with a daily preventative medication and then don their protective, pressurized suit. They may wear a dosimeter to monitor their radiation exposure. As they leave the confines of the base with its thick shielding, they look across the dusty, oxidized surface of Mars, their home for the next two years. A crewed mission to the red planet to study its history and potential for human settlement is increasingly becoming less science fiction and more of a future possibility. The ability to put boots on…
New data from John Hancock and MIT AgeLab warns most adults aren’t prepared for longer lives across care, housing, health and finances. People around the world are living longer than ever thanks to advances in medicine, public health and technology. However, a new report suggests that while lifespans are increasing, our preparedness for old age is not keeping pace… and the consequences are already showing. Fresh data from John Hancock and the Massachusetts Institute of Technology (MIT) AgeLab reveal that the number of adults entering older age is rapidly rising. Globally, people are reaching their 60s and 70s in increasing…
When gut microbial communities encounter a challenge – from medications, biotics, stress, environmental toxins, to other disruptors – their structure and function often change in unpredictable ways. This unpredictability is one factor that underlies the variable clinical response to biotic therapies. Two recent studies used advanced computational approaches to conclude that nutrients are among the most important determinants of an intestinal microbial community’s response to challenges. Drug-induced disruption linked to microbial nutrient competition Handuo Shi and colleagues of KC Huang at Stanford University tested more than 700 clinically relevant drugs on stool-derived communities in vitro. They assessed the drugs’ effects…
Credit: Mohammed Haneefa Nizamudeen/Getty Images Final results from a Phase I clinical study suggest that a preventive vaccine strategy for triple-negative breast cancer (TNBC) may be biologically feasible in humans. Investigators at Cleveland Clinic reported that an experimental vaccine targeting the lactation protein α-lactalbumin was well tolerated and elicited immune responses in most participants across three high-risk groups. The findings (PS4-06-19) were presented at the 2025 San Antonio Breast Cancer Symposium and will guide the design of a forthcoming Phase II trial. TNBC remains one of the most challenging breast cancer subtypes to address. The disease lacks estrogen, progesterone, and…
Landmark deal lifts US tariffs on UK medicines, advancing access to innovation and encouraging investment in longevity drugs. Tens of thousands of NHS patients are expected to benefit from a landmark UK–US pharmaceuticals agreement that eliminates tariffs, secures medicine supply chains and boosts investment in advanced treatments. The pact, part of the UK–US Economic Prosperity Deal, makes the UK the only country in the world with a 0% tariff on pharmaceutical exports to the United States [1]. For the UK’s fast-growing life sciences ecosystem, this represents more than preferential market access; it signals renewed confidence from global biopharma and a…
Credit: SciLifeLab What if we could simulate the cell? The basic unit of life, baring the intricate molecular networks that keep us alive and inviting scientists to endlessly unravel its secrets. Some see the virtual cell as the holy grail of biology research, while others argue it is outright impossible to ever come near simulating the full constellation of molecular interactions a cell harbors. Scientists have toyed with the concept of a virtual cell for decades. However, it is only recently that advances in biology and artificial intelligence have made it possible for them to take their first steps towards…